Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Isabel M. Berwian"'
Autor:
Isabel M. Berwian, Julia G. Wenzel, Leonie Kuehn, Inga Schnuerer, Erich Seifritz, Klaas E. Stephan, Henrik Walter, Quentin J. M. Huys
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors of relapse could guide clinical decision-making, but are yet to be established. We assessed demographic and clinical variables in a longitudinal ob
Externí odkaz:
https://doaj.org/article/973bc2975fc94fe0b6589ad0ac5aa58b
Autor:
Isabel M. Berwian, Julia G. Wenzel, Leonie Kuehn, Inga Schnuerer, Lars Kasper, Ilya M. Veer, Erich Seifritz, Klaas E. Stephan, Henrik Walter, Quentin J. M. Huys
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract The risk of relapsing into depression after stopping antidepressants is high, but no established predictors exist. Resting-state functional magnetic resonance imaging (rsfMRI) measures may help predict relapse and identify the mechanisms by
Externí odkaz:
https://doaj.org/article/ca941e685b1f456ba5afe95111594b48
Publikováno v:
Biological Psychiatry. 93:S55
Publikováno v:
Current Opinion in Behavioral Sciences
Psychological interventions are first-line treatments of depression. Despite a rich theoretical background, the mediators of treatment effects remain only partially understood: it has been difficult to precisely delineate the targets psychological in
Autor:
Leonie Kuehn, Klaas E. Stephan, Ilya M. Veer, Henrik Walter, Julia G. Wenzel, Inga Schnuerer, Quentin J. M. Huys, Isabel M. Berwian, Erich Seifritz, Lars Kasper
Publikováno v:
Scientific Reports
Scientific Reports, 10 (1)
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports, 10 (1)
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
The risk of relapsing into depression after stopping antidepressants is high, but no established predictors exist. Resting-state functional magnetic resonance imaging (rsfMRI) measures may help predict relapse and identify the mechanisms by which rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8ce1abbd1d87848a3fe160ed49e98fb
https://doi.org/10.5167/uzh-199561
https://doi.org/10.5167/uzh-199561
Autor:
Shi Qiu, Arielle S. Keller, Quentin J. M. Huys, Jason Li, Leanne M. Williams, Isabel M. Berwian
Publikováno v:
Biological Psychiatry. 89:S336-S337
Autor:
Leonie Kuehn, Klaas E. Stephan, Quentin J. M. Huys, Isabel M. Berwian, Julia G. Wenzel, Henrik Walter, Erich Seifritz, Inga Schnuerer
Publikováno v:
Scientific Reports, 12 (1)
Scientific Reports
Scientific Reports
The risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors of relapse could guide clinical decision-making, but are yet to be established. We assessed demographic and clinical variables in a longitudinal observation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea0bbf179f1c44056d31d7a4d30db894
https://doi.org/10.1101/2020.01.28.922500
https://doi.org/10.1101/2020.01.28.922500
Autor:
Klaas E. Stephan, Henrik Walter, Erich Seifritz, Isabel M. Berwian, Quentin J. M. Huys, Julia G. Wenzel
Publikováno v:
Biological Psychiatry. 89:S37
Autor:
Gábor Stefanics, Carlota de Miquel, Tania Villar, Henrik Walter, Klaas E. Stephan, Quentin J. M. Huys, Isabel M. Berwian, Marius Tröndel, Anastasios Ziogas
Background Antidepressant discontinuation is associated with a high risk of relapse. Robust predictors of relapse risk after antidepressant discontinuation could support clinical decision-making and possibly help reduce long-term prescriptions. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67677ffdfc7ed4518974c879bafc0d6
https://doi.org/10.5167/uzh-183780
https://doi.org/10.5167/uzh-183780
Autor:
Anne G.E. Collins, Klaas E. Stephan, Henrik Walter, Julia G. Wenzel, Isabel M. Berwian, Erich Seifritz, Quentin J. M. Huys
Publikováno v:
JAMA Psychiatry
IMPORTANCE: Nearly 1 in 3 patients with major depressive disorder who respond to antidepressants relapse within 6 months of treatment discontinuation. No predictors of relapse exist to guide clinical decision-making in this scenario. OBJECTIVES: To e